Related Experiment Video
Updated: Aug 14, 2026

Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures
Published on: July 27, 2022
Regulation of prostaglandin H synthase mRNA levels and prostaglandin biosynthesis by platelet-derived growth factor
A H Lin1, M J Bienkowski, R R Gorman
1Department of Cell Biology, Upjohn Company, Kalamazoo, Michigan 49008.
Abstract:
Stimulation of serum-starved NIH-3T3 cells with 20 ng/ml recombinant platelet-derived growth factor BB (rPDGF) results in the synthesis of prostaglandin E2 (PGE2) that is detectable within 10 min and which peaks after 2 h. Inhibition of translation with 36 microM cycloheximide inhibits rPDGF-stimulated PGE2 synthesis (greater than 90%), suggesting that de novo synthesis of prostaglandin H synthase (PGHS) is required for growth factor stimulation of PGE2 synthesis. Paradoxically, the addition of 10 microM exogenous arachidonate to the serum-starved cells resulted in 2-fold more PGE2 synthesis, and maximal synthesis occurred at 30 min compared to 2 h following rPDGF treatment. These data suggest that the serum-starved cells have ample biosynthetic capacity to support maximal rPDGF-stimulated PGE2 synthesis without de novo enzyme synthesis. Kinetic analysis of PGHS mRNA levels showed that although rPDGF did elevate the steady-state level of PGHS mRNA, the increase occurred after maximal PGE2 synthesis was achieved. Quantification of PGHS levels by immunoblot showed that there was no significant increase in enzyme levels following rPDGF stimulation even under conditions where PGHS mRNA levels were elevated. Irreversible inactivation of PGHS by treatment with aspirin and subsequent stimulation with rPDGF synchronized the maximal elevation of PGHS mRNA levels and PGE2 synthesis; both peaked at 3 h. Interestingly, aspirin pretreatment increased both the rate and amplitude of rPDGF-stimulated PGHS mRNA induction. The enhanced induction was not simply the result of a loss in PGE2 production since treatment with exogenous PGE2 also induced PGHS mRNA levels. Since rPDGF-stimulated PGE2 synthesis is blocked by both transcription and translation inhibitors but arachidonate-stimulated PGE2 synthesis is unaffected, the requirement for protein synthesis does not appear to involve de novo PGHS synthesis. The synthesis of a protein required for coupling of the rPDGF receptor to phospholipase activation and arachidonic acid mobilization is a more likely interpretation. In summary, our data suggest that rPDGF can induce PGHS mRNA levels, but that rPDGF-stimulated PGE2 synthesis is not dependent upon de novo PGHS synthesis.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

